An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development.

Németh, Zsófia; Pallagi, Edina; Dobó, Dorina Gabriella; Kozma, Gábor; Kónya, Zoltán; Csóka, Ildikó

Németh, Zsófia; Pallagi, Edina; Dobó, Dorina Gabriella; Kozma, Gábor; Kónya, Zoltán; Csóka, Ildikó.

Afiliación

Németh Z; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6. Eötvös u, H-6720 Szeged, Hungary.
Pallagi E; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6. Eötvös u, H-6720 Szeged, Hungary.
Dobó DG; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6. Eötvös u, H-6720 Szeged, Hungary.
Kozma G; Department of Applied and Environmental Chemistry, Faculty of Science and Informatics, Institute of Chemistry, University of Szeged, 1, Rerrich Béla tér, H-6720 Szeged, Hungary.
Kónya Z; Department of Applied and Environmental Chemistry, Faculty of Science and Informatics, Institute of Chemistry, University of Szeged, 1, Rerrich Béla tér, H-6720 Szeged, Hungary.
Csóka I; Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6. Eötvös u, H-6720 Szeged, Hungary.

Pharmaceutics ; 13(7)2021 Jul 13.

Article en En | MEDLINE | ID: mdl-34371762

Palabras clave

Quality by Design; critical factors; initial risk assessment; liposome characterisation; thin-film hydration method; updated risk assessment; "intermediate" liposome formulation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google